Page last updated: 2024-10-22

alendronate and Nausea

alendronate has been researched along with Nausea in 4 studies

alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.

Nausea: An unpleasant sensation in the stomach usually accompanied by the urge to vomit. Common causes are early pregnancy, sea and motion sickness, emotional stress, intense pain, food poisoning, and various enteroviruses.

Research Excerpts

ExcerptRelevanceReference
"Alendronate is a potent bisphosphonate that has been studied for the treatment of osteoporosis and Paget's disease of the bone."2.69Pharmacokinetics of intravenous alendronate. ( Cocquyt, V; De Grève, J; DeSmet, M; Gertz, BJ; Holland, SD; Kline, WF; Porras, AG; Quan, H; Van Belle, SJ; Vyas, KP; Zhang, KE, 1999)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's2 (50.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kajihara, Y1
Blümel, JE1
Castelo-Branco, C1
de la Cuadra, G1
Maciver, L1
Moreno, M1
Haya, J1
Cryer, B1
Binkley, N1
Simonelli, C1
Lewiecki, EM1
Lanza, F1
Chen, E1
Petruschke, RA1
Mullen, C1
de Papp, AE1
Cocquyt, V1
Kline, WF1
Gertz, BJ1
Van Belle, SJ1
Holland, SD1
DeSmet, M1
Quan, H1
Vyas, KP1
Zhang, KE1
De Grève, J1
Porras, AG1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Randomized, Double-Blind, Multicenter, Placebo-Controlled Study to Compare the Safety and Tolerability of an Oral Buffered Solution of Alendronate Sodium 70 mg Once-Weekly Versus Placebo for the Treatment of Osteoporosis in Postmenopausal Women[NCT00092027]Phase 3454 participants (Actual)Interventional2003-03-19Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

3 trials available for alendronate and Nausea

ArticleYear
Alendronate daily, weekly in conventional tablets and weekly in enteric tablets: preliminary study on the effects in bone turnover markers and incidence of side effects.
    Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology, 2003, Volume: 23, Issue:3

    Topics: Administration, Oral; Adult; Alendronate; Bone Density; Collagen Type I; Drug Administration Schedul

2003
A randomized, placebo-controlled, 6-month study of once-weekly alendronate oral solution for postmenopausal osteoporosis.
    The American journal of geriatric pharmacotherapy, 2005, Volume: 3, Issue:3

    Topics: Administration, Oral; Aged; Alendronate; Alkaline Phosphatase; Biomarkers; Bone and Bones; Collagen;

2005
Pharmacokinetics of intravenous alendronate.
    Journal of clinical pharmacology, 1999, Volume: 39, Issue:4

    Topics: Adult; Aged; Alendronate; Animals; Area Under Curve; Carbon Radioisotopes; Cricetinae; Dose-Response

1999

Other Studies

1 other study available for alendronate and Nausea

ArticleYear
An elderly woman with progressive odynophagia, epigastralgia and nausea.
    European journal of internal medicine, 2018, Volume: 57

    Topics: Abdominal Pain; Aged, 80 and over; Alendronate; Bone Density Conservation Agents; Endoscopy, Digesti

2018